|
市場調査レポート
商品コード
1767696
消化性潰瘍治療薬市場：製品タイプ別、適応疾患別、流通チャネル別、地域別Peptic Ulcer Drugs Market, By Product Type, by Disease Indication, By Distribution Channel, By Geography |
||||||
カスタマイズ可能
|
|||||||
価格
| 消化性潰瘍治療薬市場：製品タイプ別、適応疾患別、流通チャネル別、地域別 |
|
出版日: 2025年06月12日
発行: Coherent Market Insights
ページ情報: 英文 204 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
消化性潰瘍治療薬市場は、2025年には372億2,000万米ドルと推定され、2032年には493億1,000万米ドルに達すると予測され、2025～2032年にかけてCAGR4.1％で成長すると予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024年 | 2025年の市場規模 | 372億2,000万米ドル |
| 実績データ | 2020～2024年 | 予測期間 | 2025～2032年 |
| 予測期間：2025～2032年 | 4.10% | 2032年の金額予測 | 493億1,000万米ドル |
消化性潰瘍は、胃の内側と小腸の上部にできる開放性のただれです。消化性潰瘍の最も一般的な症状は胃痛です。消化性潰瘍には以下のものがあります。胃の内側にできる胃潰瘍と、小腸の上部（十二指腸）の内側にできる十二指腸潰瘍があります。消化性潰瘍の最も一般的な原因は、ヘリコバクタ・ピロリ（ピロリ菌）の感染と、イブプロフェン（アドビル、モトリンIBなど）やナプロキセン・ナトリウム（アレブ）などの非ステロイド性抗炎症薬（NSAIDs）の長期使用です。ストレスや辛い食品が消化性潰瘍の原因になることはありません。しかし、症状を悪化させることはあります。
最も一般的な消化性潰瘍の症状は、胃が焼けるような痛みです。胃酸が痛みを悪化させ、空腹時も同様です。消化性潰瘍は、胃や小腸の最初の部分に潰瘍ができることで発症します。消化性潰瘍疾患の多くは、細菌感染によって消化器系の保護膜が蝕まれて発症します。鎮痛剤を頻繁に服用する人は潰瘍を発症しやすいです。
市場力学
規制当局による製品認可の増加が、予測期間中の市場の成長を促進すると予想されます。例えば、2021年12月、製薬会社のイーデンブリッジ・ファーマシューティカルズは、米国食品医薬品局が消化性潰瘍の症状を軽減し、消化性潰瘍の治療の補助薬としてグリコピロレート口腔内崩壊錠を承認したと発表しました。
本調査の主要特徴
- 本レポートでは、世界の消化性潰瘍治療薬市場を詳細に分析し、2024年を基準年とした予測期間2025～2032年の市場規模と複合年間成長率（CAGR%）を示します。
- また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
- また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
- 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の消化性潰瘍治療薬市場における主要企業プロファイルを掲載しています。
- 本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
- 消化性潰瘍治療薬の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。
- 利害関係者は、世界の消化性潰瘍治療薬市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
- 一貫型機会マップ（COM）
第3章 市場力学、規制、動向分析
- 市場力学
- 促進要因
- 抑制要因
- 市場機会
- 影響分析
- 最近の製品リリース
- 疫学
- 合併、買収、コラボレーション
- 規制シナリオ
- PEST分析
- パイプライン分析
第4章 世界の消化性潰瘍治療薬市場、製品タイプ別、2020～2032年
- イントロダクション
- プロトンポンプ阻害剤
- カリウム競合型制酸薬（P-CAB）
- 制酸剤
- H2拮抗薬
- 抗生物質
- 潰瘍保護
第5章 世界の消化性潰瘍治療薬市場、適応疾患別、2020～2032年
- イントロダクション
- 胃炎
- 胃潰瘍
- 十二指腸潰瘍
- 胃食道逆流症（GERD）
第6章 世界の消化性潰瘍治療薬市場、流通チャネル別、2020～2032年
- イントロダクション
- 病院薬局
- 小売薬局
- オンライン薬局
第7章 世界の消化性潰瘍治療薬市場、地域別、2020～2032年
- イントロダクション
- 北米
- 米国
- カナダ
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他のラテンアメリカ
- 欧州
- 英国
- ドイツ
- イタリア
- フランス
- スペイン
- ロシア
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- ASEAN諸国
- オーストラリア
- 韓国
- その他のアジア太平洋
- 中東
- GCC諸国
- イスラエル
- その他の中東
- アフリカ
- 北アフリカ
- 中央アフリカ
- 南アフリカ
第8章 競合情勢
- Daewoong Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Pfizer Inc.
- AstraZeneca plc.
- RedHill Biopharma
- Cadila Healthcare Ltd.
- Novitium Pharma LLC.
- Boehringer Ingelheim GmbH
- Eisai Co. Ltd.
- Yuhan Corporation
- GlaxoSmithKline plc.
第9章 セクション
- 調査手法
- 出版社について
目次
Product Code: CMI3246
Peptic Ulcer Drugs Market is estimated to be valued at USD 37.22 Bn in 2025 and is expected to reach USD 49.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 37.22 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.10% | 2032 Value Projection: | USD 49.31 Bn |
Peptic ulcers are open sores that develop on the inside lining of your stomach and the upper portion of your small intestine. The most common symptom of a peptic ulcer is stomach pain. Peptic ulcers include: Gastric ulcers that occur on the inside of the stomach and Duodenal ulcers that occur on the inside of the upper portion of your small intestine (duodenum). The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve). Stress and spicy foods do not cause peptic ulcers. However, they can make your symptoms worse.
The most common peptic ulcer symptom is burning stomach pain. Stomach acid makes the pain worse, as does having an empty stomach. Peptic ulcer disease occurs when open sores, or ulcers, form in the stomach or first part of the small intestine. Many cases of peptic ulcer disease develop because a bacterial infection eats away the protective lining of the digestive system. People who frequently take pain relievers are more likely to develop ulcers.
Market Dynamics
An increase in product approval from the regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, in December 2021, Edenbridge Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration have approved glycopyrrolate orally disintegrating tablets to reduce the symptoms of a peptic ulcer and as an adjunct to treatment of peptic ulcers.
Key features of the study
- This report provides an in-depth analysis of the global peptic ulcer drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global peptic ulcer drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Daewoong Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd., Pfizer Inc., AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, GlaxoSmithKline plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global peptic ulcer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptic ulcer drugs market
Market Segmentation
- Global Peptic Ulcer Drugs Market, By Product Type
- Proton Pump Inhibitors
- Potassium-Competitive Acid Blocker (P-CAB)
- Antacids
- H2- Antagonist
- Antibiotics
- Ulcer Protective
- Global Peptic Ulcer Drugs Market, By Disease Indication
- Gastitis
- Gastric Ulcer
- Duodenal Ulcer
- Gastroesophageal Reflux Disease (GERD)
- Global Peptic Ulcer Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Peptic Ulcer Drugs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Daewoong Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Co., Ltd.
- Pfizer Inc.
- AstraZeneca plc.
- RedHill Biopharma
- Cadila Healthcare Ltd.
- Novitium Pharma LLC.
- Boehringer Ingelheim GmbH
- Eisai Co. Ltd.
- Yuhan Corporation
- GlaxoSmithKline plc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Pipeline Analysis
4. Global Peptic Ulcer Drugs Market, By Product Type, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Potassium-Competitive Acid Blocker (P-CAB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Antacids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- H2- Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Ulcer Protective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
5. Global Peptic Ulcer Drugs Market, By Disease Indication, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Gastitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Gastric Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Duodenal Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
6. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
7. Global Peptic Ulcer Drugs Market, By Region, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Daewoong Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- RedHill Biopharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cadila Healthcare Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novitium Pharma LLC.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eisai Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Yuhan Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
9. Section
- Research Methodology
- About Us
